BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34866084)

  • 1. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
    Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T
    Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
    BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
    Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
    Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
    J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
    Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW
    Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
    Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
    Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B; Chen X; Gao F; Li J; Wang HW
    Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
    [No Abstract]   [Full Text] [Related]  

  • 9. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
    Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
    Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
    N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.
    Langabeer SE; McCarron SL; Haslam K; O'Donovan MT; Conneally E
    Bone Marrow Transplant; 2014 Jun; 49(6):843-4. PubMed ID: 24614839
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.
    Dao KH; Solti MB; Maxson JE; Winton EF; Press RD; Druker BJ; Tyner JW
    Leuk Res Rep; 2014; 3(2):67-9. PubMed ID: 25180155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq.
    Sheng G; Zhang J; Zeng Z; Pan J; Wang Q; Wen L; Xu Y; Wu D; Chen S
    Cancer Genet; 2017 Oct; 216-217():16-19. PubMed ID: 29025591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
    Bartels S; Lehmann U; Büsche G; Schlue J; Hussein K; Debatin D; Karcher A; Andrulis M; Schirmacher P; Kreipe H
    Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
    [No Abstract]   [Full Text] [Related]  

  • 18. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R
    Parducci NS; Garnique ADMB; Lima K; Carlos JAEG; Fonseca NP; de Miranda LBL; de Almeida BO; Rego EM; Traina F; Machado-Neto JA
    Blood Cells Mol Dis; 2024 Jan; 104():102799. PubMed ID: 37839173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for
    Ye P; Lin Q; Jin M; Gu X; Lu Y
    Turk J Haematol; 2023 Feb; 40(1):73-74. PubMed ID: 36510384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.